234 related articles for article (PubMed ID: 31528096)
1. Growth arrest-specific gene 2 suppresses hepatocarcinogenesis by intervention of cell cycle and p53-dependent apoptosis.
Zhu RX; Cheng ASL; Chan HLY; Yang DY; Seto WK
World J Gastroenterol; 2019 Aug; 25(32):4715-4726. PubMed ID: 31528096
[TBL] [Abstract][Full Text] [Related]
2. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL
J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
[TBL] [Abstract][Full Text] [Related]
4. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
6. Cyclin E facilitates dysplastic hepatocytes to bypass G1/S checkpoint in hepatocarcinogenesis.
Pok S; Wen V; Shackel N; Alsop A; Pyakurel P; Fahrer A; Farrell GC; Teoh NC
J Gastroenterol Hepatol; 2013 Sep; 28(9):1545-54. PubMed ID: 23574010
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of tumor suppressor p33(ING1b) and its synergy with p53 gene in hepatocellular carcinoma.
Zhu Z; Lin J; Qu JH; Feitelson MA; Ni CR; Li FM; Zhu MH
World J Gastroenterol; 2005 Apr; 11(13):1903-9. PubMed ID: 15800978
[TBL] [Abstract][Full Text] [Related]
8. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.
Wang H; Yang Z; Liu C; Huang S; Wang H; Chen Y; Chen G
Biochem Biophys Res Commun; 2014 Nov; 454(1):71-7. PubMed ID: 25445601
[TBL] [Abstract][Full Text] [Related]
9. SIX1 and DACH1 influence the proliferation and apoptosis of hepatocellular carcinoma through regulating p53.
Cheng Q; Ning D; Chen J; Li X; Chen XP; Jiang L
Cancer Biol Ther; 2018 May; 19(5):381-390. PubMed ID: 29333942
[TBL] [Abstract][Full Text] [Related]
10. PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27
Tuo L; Xiang J; Pan X; Hu J; Tang H; Liang L; Xia J; Hu Y; Zhang W; Huang A; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Feb; 38(1):50. PubMed ID: 30717766
[TBL] [Abstract][Full Text] [Related]
11. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
[TBL] [Abstract][Full Text] [Related]
13. lncRNA HOXB-AS3 promotes hepatoma by inhibiting p53 expression.
Zhang XM; Chen H; Zhou B; Zhang QY; Liao Y; Wang JS; Wang ZH
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6784-6792. PubMed ID: 30402841
[TBL] [Abstract][Full Text] [Related]
14. Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression.
Hao PP; Li H; Lee MJ; Wang YP; Kim JH; Yu GR; Lee SY; Leem SH; Jang KY; Kim DG
J Hepatol; 2015 Jun; 62(6):1278-86. PubMed ID: 25617504
[TBL] [Abstract][Full Text] [Related]
15. Dual roles of glutathione S-transferase mu 1 in the development and metastasis of hepatocellular carcinoma.
Lu Y; Zhou J; Zhang J; Wang Z; Yu Y; Miao M; Yao Q
Biomed Pharmacother; 2019 Dec; 120():109532. PubMed ID: 31605953
[TBL] [Abstract][Full Text] [Related]
16. ZNF498 promotes hepatocellular carcinogenesis by suppressing p53-mediated apoptosis and ferroptosis via the attenuation of p53 Ser46 phosphorylation.
Zhang X; Zheng Q; Yue X; Yuan Z; Ling J; Yuan Y; Liang Y; Sun A; Liu Y; Li H; Xu K; He F; Wang J; Wu J; Zhao C; Tian C
J Exp Clin Cancer Res; 2022 Feb; 41(1):79. PubMed ID: 35227287
[TBL] [Abstract][Full Text] [Related]
17. Mediator subunit 23 overexpression as a novel target for suppressing proliferation and tumorigenesis in hepatocellular carcinoma.
Guo Y; Wang J; Li H; Liu W; Chen D; Zhao K; Liang X; Zhang Q; Yang Y; Chen G
J Gastroenterol Hepatol; 2015 Jun; 30(6):1094-103. PubMed ID: 25684393
[TBL] [Abstract][Full Text] [Related]
18. Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma
Kang X; Wang F; Lan X; Li X; Zheng S; Lv Z; Zhuang Y; Zhao Y; Zhou S
Int J Med Sci; 2018; 15(1):69-76. PubMed ID: 29333089
[No Abstract] [Full Text] [Related]
19. Dbx2 exhibits a tumor-promoting function in hepatocellular carcinoma cell lines
Hu YT; Li BF; Zhang PJ; Wu D; Li YY; Li ZW; Shen L; Dong B; Gao J; Zhu X
World J Gastroenterol; 2019 Feb; 25(8):923-940. PubMed ID: 30833799
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
Guo J; Wang M; Wang JP; Wu CX
World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]